A successful and independent Corporation
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
Boehringer Ingelheim
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Boehringer Ingelheim Middle East and Africa (MEA)
Boehringer Ingelheim initiated its operations in in the Middle East and Africa over 60 years ago in Egypt; today the company’s reach spreads to sales operation in 20 countries within MENA with a regional office in Dubai. The regional office in Dubai has then expanded its regional hub responsibility to manage the Middle East, Turkey and Africa (META) region.
Boehringer Ingelheim MEA is now one of the leading multinational pharmaceutical companies in the region with a team of over 1169 employees.
Boehringer Ingelheim is dedicated to bringing innovative health care products in human pharmaceuticals and animal health to the Middle East and Africa (MEA) region, through presence of scientific offices in UAE, Algeria, KSA, and Egypt. Boehringer Ingelheim operates in the rest of the MEA region through partners and third party distributors.
Boehringer Ingelheim’s businesses are divided into Human Pharma and Animal Health.
Human Pharma brings innovative products for different disease areas and is aimed at providing effective primary and specialty care across various indications, in order to improve the quality of life of patients in the Middle East and North Africa.
- Respiratory diseases
- Cardiovascular diseases
- Metabolic diseases - Type 2 Diabetes
- Oncology
Animal Health provides innovative solutions in the Middle East and Africa region, which improve health in:
- Livestock
- Companion Animals
- Poultry
Value through Innovation is the central concept of Boehringer Ingelheim’s corporate vision.
At Boehringer Ingelheim MEA, providing the best possible care to patients is paramount. We thrive to infuse our corporate vision in to our business in the Middle East and North Africa by delivering effective disease awareness campaigns, supporting local healthcare communities and collaborating with governments and health authorities to provide a better quality of live to patients.
Corporate Social Responsibility: Social responsibility is an important element of Boehringer Ingelheim MEA. This includes region-wide involvement in social projects, such as the initiative “Making More Health”, creating disease awareness campaigns, educational programs and supporting local health authorities across MEA in providing better health awareness and care to patients.
-
-
Our Company
Together we shape the future of healthcare. Read more on how partnerships and long-term cooperation drive our daily work.
-
Our Global Support Program
-
COVID-19
As a company, we consider it our duty to take the best possible care of the protection and health of our employees, our patients and society. Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19.
-
DOWNLOAD PDF (503.33 KB)
-
Careers
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
-
Our Company
-
History
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim.
-
-
Our Company
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees.
-
Corporate
Get an overview of the major consolidated companies and our main business areas Human Pharmaceuticals and Animal Health
-
Corporate Responsibility
-
Our Company
-
Corporate Citizenship
As a service to society, Boehringer Ingelheim’s research and development focuses on a variety of external partnerships.
-
Management
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of seven members. Read more about their respective responsibilities.
-
Financial
Net sales, Research & Development, Operating Income and Personnel Capacity: Boehringer Ingelheim has a stable and healthy financial situation with long term growth.
-
Corporate Citizenship
For more than five decades, the art exhibition "Internationale Tage" (International Days) in Ingelheim has been one of Boehringer Ingelheim’s cultural commitments.
-
Making More Health
Our global MMH initiative identifies and supports innovative health solutions by focusing on social entrepreneurial activities and co-creation
-
Employees
Our Employees
The employees of Boehringer Ingelheim form the core of our corporate culture as a family-owned company that lives out its responsibility and builds on mutual respect and fairness.